All posts by imreal

The Receptionist announces contactless visitor check-in experience with latest version release


News Image

“By making our contactless feature available immediately to everyone using our software, we believe we’re helping our customers keep their visitors and their employees safer and healthier.” — Andy Alsop, The Receptionist President and CEO

The Receptionist today announced the release of a new Contactless Check-In option for its visitor management system as a way to reduce contact liabilities in businesses and facilities and help minimize the risk of spreading any virus or disease.

After months of intensive research into different screening procedures, interviews with customers to determine needs, and internal product testing, the rollout of the new contactless functionality prioritizes keeping visitors and employees safe during the check-in process when the chances of using shared equipment are at their highest.

“Business leaders around the world have had to rethink how they welcome visitors through their doors in the wake of the COVID-19 pandemic,” said Andy Alsop, President and CEO of The Receptionist. “We wanted to ensure that any solution we produced in response to this need would add lasting value to our customers not only during this time, but far into the future. By making our contactless feature available immediately to everyone using our software, we believe we’re helping our customers keep their visitors and their employees safer and healthier.”

The Receptionist for iPad‘s contactless feature allows office visitors to check in using their personal mobile device, without needing to physically touch an iPad kiosk or download an additional app, and at no additional cost.

Upon arrival, visitors can use their mobile device’s camera to scan a QR code displayed on the iPad screen, launching a browser that walks them through answering each company’s unique visitor check-in questions.

Additionally, visitors can start the process prior to their arrival by accessing a unique URL provided by the business. They will then be able to answer any questions ahead of their scheduled visit.

Once they’ve answered the check-in questions, visitors will be given a unique QR code on their mobile device to present to the iPad’s camera that will complete their check in and notify the appropriate contact that their visitor has arrived.

Feedback from Receptionist for iPad customers has been overwhelmingly positive in the initial days since the contactless feature’s release.

“As a community of independent health and wellness providers, protecting the health and safety of our Members and their clients and patients is at the forefront of what we do,” said Scott Zimmerman, Founder and CEO of Nexis Wellness. “The Receptionist for iPad has been a critical tool at Nexis for the past three years, and we are confident that our visitors are going to love using the new contactless check in process.”

The initial release of the contactless feature includes the ability to have visitors sign health, security, and/ or liability agreements/statements digitally and print badges (if a printer is available) once a visitor has scanned their QR code to confirm their check-in and log their Covid-19 risk.

Planned future updates include functionality to recognize returning visitors, take photos from the mobile device, search contacts, and more.

“We see contactless visitor check-ins becoming much more the standard rather than the exception moving forward,” said DeLynn Berry, The Receptionist Co-Founder and Director of Engineering, “and we’re going to continue to place our resources into additional functionality that provides our customers and their guests the best experience possible.”

Share article on social media or email:

AHN West Penn Hospital Named one of Nation’s Top 100 Hospitals


West Penn Hospital, part of Allegheny Health Network (AHN.)

West Penn Hospital, part of Allegheny Heath Network (AHN), has been named one of the nation’s 100 Top Hospitals by IBM Watson Health™ for the second consecutive year.

The new report, published this week in Fortune magazine, spotlights the top-performing hospitals in the United States, based on a scorecard of publicly available clinical, operational, safety, financial, and patient satisfaction data.

IBM Watson Health™ recognizes hospitals of all sizes, in five different categories – major teaching hospitals, teaching hospitals, large community hospitals, medium community hospitals, and small community hospitals.

West Penn is among 25 facilities recognized in the “teaching hospitals” category. It is one of just two hospitals in the Pittsburgh area, and one of four in Pennsylvania, to be named to the 100 Top Hospitals® list.

“We are extremely proud to be named one of the nation’s top hospitals by one of the country’s most respected health care industry analysts,” said Ron Andro, president of West Penn Hospital. “This honor again is reflective of the extraordinary talent and dedication of our physicians, nurses, volunteers, and employees at every level.”

This year marks the sixth time that West Penn Hospital has been named to the prestigious Top 100 Hospitals list, which has been published annually since 1993. To create its 2020 list, IBM Watson Health™ researchers evaluated more than 3,100 short-term, acute care, non-federal U.S. hospitals.

“West Penn Hospital has always held a special place in the hearts of those who are cared for within its walls, and this recognition by IBM Watson Health is a wonderful validation of the clinical excellence and compassion that the hospital’s caregivers provide every day to those in need,” said Cindy Hundorfean, AHN President and CEO. “We can’t express enough how grateful we are to Ron Andro and everyone at West Penn for consistently raising those standards.”

The Watson Health 100 Top Hospitals® study uses independent and objective research to analyze hospital performance in areas such as clinical outcomes, operational efficiency, patient experience and financial health. IBM Watson Health established the list to help identify best practices that may help other health care organizations achieve consistent, balanced, and sustainable high performance.

A cornerstone of Pittsburgh’s Bloomfield neighborhood, West Penn is a 333-bed teaching hospital and tertiary care facility. Among the many leading clinical programs based at the hospital are AHN’s Women’s Institute, Autoimmunity Institute, Esophageal and Lung Institute, blood and marrow transplant program, and the West Penn Burn Center.

The hospital continues to evolve and expand its clinical programs. In 2019, the hospital cut the ribbon on its expanded Level III neonatal Intensive Care Unit, and in the same year opened three new cancer care facilities for patients with breast, gynecologic and hematologic cancers.

In 2018, the hospital opened a first-in-the-region Healthy Food Center, which provides fresh, healthful foods to patients with diabetes who are screened by their doctor as being food insecure. West Penn is also home to the Alexis Joy D’Achille Center for Perinatal Mental Health, a one-of-a-kind program and facility dedicated to caring for women with post-partum depression and other anxiety disorders.

West Penn also was the first hospital in Pittsburgh to earn the American Nurses Credentialing Center’s Magnet Recognition, the nation’s most prestigious honor for nursing excellence.

According to IBM Watson Health, compared to similar hospitals, the hospitals included on the Fortune and IBM Watson list had better results on key clinical and operational performance indicators. These include survival rates, patient complications, healthcare associated infections, 30-day mortality and 30-day hospital-wide readmission rates, length of stay, throughput in emergency rooms, inpatient expenses, profitability, and ratings from patients.

“Hospitals, health systems, and the dedicated clinicians and staff who work at these organizations have emerged as true heroes of the COVID-19 pandemic and we are grateful to be able to recognize these extraordinary leaders at this time,” said Kyu Rhee, M.D., M.P.P., Vice President and Chief Health Officer, IBM Watson Health.

“From small community hospitals to major teaching hospitals, organizations on this list demonstrate a relentless commitment to high value, patient-centered care and innovation. It is clear that the COVID-19 crisis will be a catalyst for reinvention, and we believe these top performing hospitals are positioned to emerge stronger and smarter out of this crisis.”

For more information, visit http://www.100tophospitals.com.

###

COVID-19 Prompts Healthcare Firms To Buy Isopropyl Alcohol


Lab Alley has been helping healthcare firms as they face historic challenges during the COVID-19 pandemic by shipping isopropyl alcohol (IPA) to their facilities. Hand hygiene is an important part of the U.S. response to the international emergence of COVID-19. IPA is an important ingredient in hand sanitizers and other disinfectants used for protection against the virus. “Isopropyl alcohol is a cleaner that neutralizes the coronavirus on everything from countertops to medical devices,” says Fred Elabed, CEO of Lab Alley LLC.

Rubbing alcohol, hand sanitizers, and disinfecting pads normally contain a 60-70% solution of isopropyl alcohol in water. Even as wholesale isopropyl alcohol prices tripled and shortages escalated, Lab Alley continued to ship isopropyl alcohol to hospitals, universities, governments, healthcare firms, healthcare workers, first responders and other medical providers.

In March and April of 2020, the coronavirus pandemic sparked price surges and a leap in demand for isopropyl alcohol which pushed prices to record highs in the U.S. Throughout the COVID-19 pandemic, Lab Alley has continued to ship 1 gallon bottles, 5 gallon pails and 55 gallon drums of 70%, 91% and 99% isopropyl alcohol solutions to healthcare facilities and healthcare providers throughout the United States. While retailers, pharmacies and major grocery chains either ran out of isopropyl alcohol or placed limits on purchases, Lab Alley continued to supply the healthcare and personal care firms with isopropyl alcohol (IPA) in bulk.

When COVID-19 became a health crisis in the United States in March of 2020, a persistent shortage of hand sanitizers began affecting hospitals, medical offices, clinics, dental practices, and healthcare facilities. Isopropyl alcohol (Formula C3H8O) purchased online in bulk at LabAlley.com is currently being used by healthcare practitioners for formulating and compounding alcohol-based hand sanitizers during the public health emergency. Hand sanitizers with a final concentration of at least 70% isopropyl alcohol inactivate viruses that are genetically related to, and with similar physical properties as, the COVID-19 virus. A final concentration of 75% isopropyl alcohol recommended in the USP hand sanitizer toolkit is aligned with the World Health Organization (WHO).

Healthcare and personal care firms in the United States have also been ordering hospital grade disinfectants, hydrogen peroxide, pure ethanol, denatured ethanol, glycerin, benzalkonium chloride, and other antiviral products online at LabAlley.com during the COVID-19 pandemic. Private consumers and business owners have also been buying ingredients online at LabAlley.com to make their own hand sanitizers, coronavirus disinfectant sprays, disinfectant solutions and products, surface cleaners, and antiseptic towelettes.

Lab Alley even shipped isopropyl alcohol to liquor distilleries that retooled to help combat the hand sanitizer shortage caused by the virus. As the coronavirus pandemic continues to spread across the country, Lab Alley continues to ship isopropyl alcohol (IPA) and other sanitizing and disinfectant products to businesses and individuals to help prevent the spread of COVID-19 and other viral respiratory illnesses.

Lab Alley is an “essential business” during COVID-19 providing sanitizing and disinfectant chemicals to hospitals, healthcare, personal care/health & beauty/cosmetics, healthcare workers, first responders, medical providers, universities, governments, businesses, and consumers.

About Lab Alley

Lab Alley LLC is a woman-owned small business enterprise that supplies laboratory chemicals and reagents, laboratory chemical solvents, and laboratory consumables to Healthcare, Personal Care/Health & Beauty/Cosmetics, Biotech, Life Science, Pharmaceutical, R&D, Laboratory, Industrial, Academia/Education, CBD/Hemp, and Government Agencies. We actively market our product portfolio to customers within our targeted market segments. Our chemicals and reagents categories include Ethanol, Solvents, Acids, Bases and Caustics, Buffers, Salts and Inorganic Chemicals, and Solutions.

Lab Alley also supplies Antivirals, COVID-19 Disinfectants, and Hand Sanitizer Ingredients, and other chemicals and reagents.

Located in the heart of the Austin, Texas, Lab Alley was established with the express goal of offering a cohesive buying experience for laboratories throughout the country and around the world. Our extensive product line and diverse branding are uniquely fitted to meet the needs of our customers. Our comprehensive product website and trained staff are adept at finding the perfect solution for each customer.

For a complete listing of our product portfolio please visit our website at http://www.laballey.com.

Share article on social media or email:

Xtalks Announces Its Life Science Webinar Calendar for July 2020


Xtalks Life Science Webinars

Stay on top of current hot topics through free webinars presented by leading experts in pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Visit http://www.xtalks.com to see our upcoming webinars:

CLINICAL TRIALS

July 2- Optimizing Clinical Trials Using Adaptive Design: Early Alignment for Success

July 6- Bringing Clarity and Focus to Research Questions: ICH E9 (R1) Estimands and Sensitivity Analyses in Clinical Trials

July 7- Clinical Endpoints and Treatment Effect in Immuno-Oncology

July 9- Achieving High Performance Study Start-up: An Inside Look at GSK

July 13- The Impact of COVID-19 on Early Clinical Development – What the New Landscape Will Look Like

July 14- Adapting Oncology Clinical Research Practices and Therapeutic Development Strategies in the Global COVID-19 Era

July 14- How Multispectral Imaging Enables Analysis of Macrophages in Chronic Liver Disease

July 14- Demystifying Decentralized Clinical Trials and Enabling Your Study for Success

July 16- Strategic Considerations for Successful Biosimilars Development

July 16- iRECIST Criteria: An Operational Approach in Oncology Clinical Trials

July 17- Protein Therapeutic Bioanalysis by Hybrid IA-LC-MS/MS: Optimization of a Preclinical Antibody Workflow

July 20- Accelerate Biomarker Discovery: Learn How to Mine Data for Actionable Insights

July 21- Ready or Not, COVID-19 Necessitates the Move to Decentralized Clinical Trials

July 21- Anatomy of a Successful Study Transition: If I Knew Then What I Know Now

July 23- The Evolving Role and Accelerated Adoption of Data Management Technology Strategies and Solutions

July 28- How Alcon Enabled Data Managers to Build Studies Directly from the Protocol

July 29- Phase I Studies in Patient Populations: De-risking Clinical Development by Obtaining Key Patient Data Earlier

July 29- Diabetes and CKD: The Patient Experience, Clinical Research and the Promise of Precision Medicine

July 30- Integrating Qualitative Patient Interviews into a Clinical Trial Protocol

DRUG DISCOVERY AND DEVELOPMENT

July 7- Cost-Efficient and Green Manufacturing of Peptides Thanks to Molecular Hiving Technology

July 8- CRISPR Generated Models: A Framework for Reducing Risk and Timelines Through Careful Design and Planning for Downstream Services

July 10- LBA and Hybrid LCMS Quantitation of Biotherapeutics and Biomarkers

July 13- Biomarkers in Immuno-Oncology: Identifying and Implementing Biomarker Testing from Exploratory Research to Clinical Trials

July 15- The Role of the Laboratory Animal Diet in Shaping the Gut Microbiota

July 22- Remote Administration Considerations for Conventional and Computerized Clinical Outcome Assessments

July 23- Database Mapping: A Tool to Identify Real World Data Sources

FOOD

July 15- Re-discover the More Planet-Friendly Way of Packaging: PAPER

July 22- Delivering Sustainable Business Benefits and ROI with FoodTech

MEDICAL DEVICES

July 8- Successfully Navigating Cost Barriers to Deliver Low Cost Connectivity to the Pharmaceutical Industry

July 9- The Future of Medical Devices: How COVID-19 and the Rise of Digital Health has changed Regulatory, Clinical, and Reimbursement Dynamics in the Medical Device Industry

July 13 – Drive Manufacturing Resilience Through the Virtual Twin Experience In Life Sciences

PHARMACEUTICAL

July 7- Optimize your Supply Chain with End-to-End Visibility

July 15- How to Comply with the New Revision of USP 1058 under a Lockdown

July 20- Implementing Precision Medicine: Diagnostics Policy Considerations for Biopharmaceutical Innovators

July 20- Applying AI and Cloud Technologies for Multivariate Control in Upstream Processes

July 22- COVID-19: Navigating the New Normal in Pharmaceutical Commercialization

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com.

Share article on social media or email:

a timely new humorous journaling book for everyone


SOCIALLY DISTANCED A Keepsake Journal Book Cover

According to Robert Stern, author of SOCIALLY DISTANCED A Keepsake Journal, I recognized that we are all in an important time in our lives with the Pandemic and wanted to provide some humor and an interactive journal to help.

How can everyone better cope with the on-going Pandemic? Here’s one solution…a fun new book that combines humor and journaling to help us better deal with what’s happening today.

SOCIALLY DISTANCED A Keepsake Journal was written by author Robert Stern in humorous rhyme accompanied by delightful illustrations, with lots of room in the paperback book or e-book version to record our thoughts and activities during the COVID-19 period. It enables everyone to create something special to keep and look back on in better times and remember how we got through it all!

For parents of children ages 12 and older, this is a great tool to help kids feel better while writing down their positive and negative feelings about the situation. For all adults, this book also inspires them to record what these weeks are like for each individual. It also makes a thoughtful gift for anyone who has helped during these recent months.

According to Robert Stern, author of SOCIALLY DISTANCED A Keepsake Journal, “I recognized that we are all in an important time in our lives with the Pandemic and wanted to provide some humor and an interactive journal to help. As we know, life is often challenging. Nothing is permanent and every day is a new one to feel more positive and in control of your life. In fact, many experts recommend journaling because it can improve your mood and may be good for your mental health. I believe this book can provide a cathartic experience to help us all!”

SOCIALLY DISTANCED A Keepsake Journal is 32-page book written in light-hearted rhyme with colorful illustrations. is available in a quality paperback for $9.95 or $6.95 for a downloadable e-version from the website, sociallydistantjournal.com. ISBN 978-0-9801988-9-8

Synopsis:

SOCIALLY DISTANCED A Keepsake Journal

The Coronavirus Pandemic caused us to react to a changing environment. So many different issues for so many people from personal health to the health of loved ones. Loss of employment. Government restrictions. Caring for school aged children as schools closed. Impact on travel and vacations. Finding toilet paper. Politics and so much more. Here is an opportunity to laugh a little, and record your thoughts as a keepsake for yourself, your children, and your grandchildren to read years later. Here’s an opportunity to tell a friend how much you appreciate their support either by buying them a copy to journal their experience, or sharing your feelings as a thank you. Perhaps you can record what you did to pass the time. Who were you concerned for? What provisions you stocked up on? How you were hurting economically, and what you had to do to survive. Share the activities you missed the most, and how your mood changed during the lockdowns. Journal what’s important to you.    

About the Author:

Robert Stern, the author of SOCIALLY DISTANCED A Keepsake Journal, has always enjoyed writing rhymes for books, wedding toasts and other occasions. He teamed up with talented illustrator, Mark Hill, to create this helpful book. Formerly a Hollywood entertainment executive at 20th Century Fox and New World Entertainment, Stern previously wrote other non-fiction books including HOA WARS and A Legend in My Own Mind and Other Stupid Thoughts. As the Pandemic continued, he picked up his pen to create another book hoping to help us all!

Share article on social media or email:

Everest Group Predicts IDP Market Growth Acceleration in 2021


Everest Group

Automated extraction of data using IDP solutions will enable organizations to process large volumes of semi-structured and unstructured documents with low-touch processing, greater accuracy, and faster turnaround times, thus helping deal with volume fluctuations as well.

Everest Group reports that the Intelligent Document Processing (IDP) market generated US$540 – $560 million in revenues in 2019 and achieved a nearly 60% growth from 2018 to 2019. However, Everest Group recently scaled back its 2020 growth projections for the IDP market by 50%, revising its original estimate of 50-60% CAGR to 27-30% due to the impact of the COVID-19 crisis.

Everest Group defines Intelligent Document Processing (IDP) as any software product or solution that captures data from documents (e.g., email, text, pdf, and scanned documents), categorizes and extracts relevant data for further processing using artificial intelligence (AI) technologies such as computer vision, optical character recognition (OCR), Natural Language Processing (NLP), and machine/deep learning (ML/DL).

“The IDP technology vendor market is certainly impacted due to the ongoing COVID-19 crisis and is currently experiencing a short-term dip in volumes and growth; however, as the economy recovers, we expect the IDP market to witness accelerated demand,” said Anil Vijayan, vice president at Everest Group. “Adoption of automation products in general, and IDP products specifically, will intensify considerably, particularly in those industries such as banking, insurance and healthcare, which are already leading the way in adopting IDP solutions. Post-COVID 19, these industries will seek to accelerate low-touch processing and faster turnaround times through automated extraction of data.”

“Several of the benefits of IDP solutions are being accentuated by the current crisis,” continued Vijayan. “For example, post-COVID-19, enterprises will want to automate as much as possible to reduce dependence on the human workforce and to cut costs. Automated extraction of data using IDP solutions will enable organizations to process large volumes of semi-structured and unstructured documents with low-touch processing, greater accuracy, and faster turnaround times, thus helping deal with volume fluctuations as well.”

Banking, financial services and insurance (BFSI) and healthcare enterprises continue to

be the major adopters of IDP solutions, together accounting for a 50% share of the market. Growth in each of these segments between 2018 and 2019 was significant, with BFSI posting a 50% CAGR and healthcare growing at 65-75%. BFSI use cases include customer onboarding, mortgage processing, trade financing and claims processing. Invoice processing, Know Your Customer (KYC) paperwork to prevent medical identity fraud, insurance claims, patient onboarding, and patient records are among the most common healthcare use cases of IDP solutions.

These findings are discussed in more detail in Everest Group’s recently published report “Intelligent Document Processing (IDP) State of the Market Report 2020 – Leave No Page Unturned With AI.” This research provides a detailed view of the current state of the IDP technology market, including market size and adoption trends, buyer satisfaction, product capabilities and trends, solution characteristics, vendor landscape, challenges to IDP adoption.

The report also offers Everest Group’s outlook for the IDP Market for 2020-2021. Trends expected for the coming year include:

  • Package-based IDP solutions will become more prevalent due to the need for faster deployment.
  • The current global pandemic will lead to more receptiveness among enterprises toward cloud-based solutions.
  • Enhanced product capabilities such as software learning, user-friendly interfaces, pre-trained models, better integration with enterprise IT architecture, and security and data protection enhancements will make IDP adoption more attractive.

*** Download Complimentary Abstract ***

About Everest Group

Everest Group is a consulting and research firm focused on strategic IT, business services, engineering services, and sourcing. Our clients include leading global enterprises, service providers, and investors. Through our research-informed insights and deep experience, we guide clients in their journeys to achieve heightened operational and financial performance, accelerated value delivery, and high-impact business outcomes. Details and in-depth content are available at http://www.everestgrp.com/.

Share article on social media or email:

Feature Updates on Recent Imaging Trends Covering COVID-19, Physics Standards, and Employer Purchasing Requirements


News Image

RadSite™, a leading accreditation organization promoting quality-based imaging practices, announced today its summer webinar series on updates to key accreditation standards. The webinars address how COVID-19 is impacting imaging practices, the need for uniform physics requirements for Cone Beam CT imaging systems, and a national employer initiative to promote quality- and performance-based imaging.

The three webinars are:

Impact of COVID-19 on Imaging Providers

July 15th, 2020

2 p.m. to 3 p.m. ET

This webinar will feature an overview of how the coronavirus pandemic is impacting imaging providers and other healthcare professionals. The speakers will share different perspectives on what medical practices, hospitals, employers, and others are doing to ensure a safe and productive workplace for patients, providers, and employees.

Moderator: Mark Casner, RadSite Chair, Accreditation Committee

Speakers:

  • Charlie Shaw, RadNet SVP Healthcare Network Strategy & Business Development (imaging provider)
  • Michael Thompson (employer perspective)
  • Phil Patton, PhD, RadSite Chief Physicist Officer (physicist perspective)
  • Eliot Siegel, MD, RadSite Medical Director (hospital perspective)

Click here to learn more about this webinar and to register.

Moving to a Uniform Physics Testing Protocol for Cone Beam CT Imaging

August 12th, 2020

2 p.m. to 3 p.m. ET

This webinar will present future enhancements to standards and practices associated with Cone Beam CT imaging. Several physicists will discuss how they are collaborating on development of a uniform phantom that will help standardize physics testing for different Cone Beam CT imaging systems. The presenters will provide a detailed overview on how Cone Beam CT imaging systems operate and how to optimize clinical and quality outputs through standardized measurement protocols.

Moderator: Eliot Siegel, MD, RadSite’s Standards Committee Chair

Speakers:

  • Jeff Siewerdsen, PhD, Professor, Dept of Biomedical Engineering, Johns Hopkins University
  • John M. Boone, PhD, Professor of Radiology and Chief of Medical Physics, Professor of Biomedical Engineering, University of California Davis Medical Center
  • Joshua Levy, President, The Phantom Lab

Click here to learn more about this webinar and to register

Highlighting Imaging Quality and Performance Best Practices

September 24th, 2020

2 p.m. to 3 p.m. ET

In this webinar, several imaging and quality experts will discuss ways to optimize imaging practices. Speakers will address a number of provider practice and payer initiatives, including new benchmarks under development by the eValue8 Medical Imaging Quality Workgroup. The Workgroup is sponsored by the National Alliance for Healthcare Purchasing Coalitions, Radiology Benefit Management (RBM) organizations, and RSNA’s Quantitative Biomarkers Alliance.

Moderator: Garry Carneal, JD, President & CEO, RadSite

Speakers:

  • Patrick Browning, MD, Radiologist
  • John B. Miller, eValue8 Chair, National Alliance
  • Suresh K. Mukherji, MD, MBA, FACR, Neuroradiologist

Click here to learn more about this webinar and to register

RadSite offers comprehensive, affordable, quality-based accreditation programs that evaluate imaging providers on established industry standards, regulatory requirements, and best practices. Working with health plans and their participating providers also helps raise imaging standards through meaningful imaging quality and patient safety protocols. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services and more than 350 payers and radiology benefit managers.

To learn more about RadSite, visit http://www.radsitequality.com. Click here to learn more about RadSite’s previous and upcoming webinars.

                                                                        ###

About RadSite™ (http://www.RadSiteQuality.com)

Founded in 2005, RadSite’s mission is to promote quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite’s programs help assess, track, and report imaging trends in an effort to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.

Share article on social media or email:

NeoTract Designates Dr. Kathy Ravanbakhsh as UroLift® Center of Excellence


News Image

“Dr. Kathy Ravanbakhsh has earned the UroLift Center of Excellence designation for her dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Kathy Ravanbakhsh, D.O., CHI St. Joseph Health in Bryan, TX, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Ravanbakhsh has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Kathy Ravanbakhsh has earned the UroLift Center of Excellence designation for her dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Samsung-Accelerated Startup Luple Launches Light Technology Devices That Help Users Balance Their Circadian Rhythms


News Image

We’ve heard many stories from people who rely on sleeping pills or excessive amounts of caffeine, and we wanted to provide something that would help people stabilize their biological rhythms in a more natural way.

Olly, a light technology device from Samsung’s startup incubator, has launched on Kickstarter and has reached its funding goal in just 3 hours. The product is dedicated to helping users find balance in their everyday routines and comes in two versions—Olly Day, which helps users stay awake during the day, and Olly Night, which encourages deeper and more holistic sleep at night.

Olly Day’s wavelengths mimic sunlight to keep users feeling energized and to provide a natural energy boost without the side effects commonly associated with caffeine. The device boosts focus in just 20 minutes and can work more effectively and quickly than a cup of espresso.

Unlike LED lights that suppress the natural production of melatonin in the body, Olly Night’s wavelengths encourage melatonin production to prepare users for a night’s rest. The device emits a warm light and automatically turns off in 30 minutes.

“There’s been a significant uptick in the amount of people who are now working from home, and this transition can throw circadian rhythms off balance. We’ve heard many stories from people who rely on sleeping pills or excessive amounts of caffeine, and we wanted to provide something that would help people stabilize their biological rhythms in a more natural way,” said Ardor, the founder and CEO of Luple.

Each device is compact, portable and can be used simply by placing it on its magnetic lid and angling the light at a tilt. Olly takes two hours to fully charge with a USB-C cable, and a single charge can run for six hours.

Pre-orders of Olly Day and Olly Night will be available for a limited time on the product’s Kickstarter page, and it is a consumer-ready product. The Early Bird Single Packs start at $49 and come with a cable and a pouch. The team anticipates that delivery will be complete by October 2020.

About Luple

Backed by Samsung’s startup accelerator program, Luple creates products dedicated to helping people live their most productive and energized lives. By using human-centric lighting technology, Olly encourages wellness through natural solutions. For more information, visit http://olly.luple.co.kr.

Share article on social media or email:

“In Depth” with Laurence Fishburne Program Covers Caring For Patients with Chronic Conditions


News Image

People with chronic diseases need more than a diagnosis and prescriptions – they need a person-centered approach where they feel their preferences, values, and needs are considered, along with clinical decisions.

Prolific actor Laurence Fishburne gained widespread acclaim for his gripping performances in the Tina Turner biopic “What’s Love Go To Do With It (1993)” and “Hoodlum (1997).” Now the award-winning actor is hosting an educational segment for the program “In Depth” with Laurence Fishburne. The informational television program showcases industry experts to discuss a variety of topics that affect people all over the country. A new episode will take a plunge into the medical field. Medical professionals will discuss how to provide proper care for patients experiencing chronic health conditions.

Nearly 50 percent of all adults have one or more chronic health conditions, and one of four adults have at least two or more chronic health conditions. Long-term illnesses like heart disease, stroke, and cancer are the leading cause of mortality rates worldwide. Despite alarming figures, the healthcare system lacks the structure to handle chronic illness adequately.

People with chronic diseases need more than a diagnosis and prescriptions – they need a person-centered approach where they feel their preferences, values, and needs are considered, along with clinical decisions. Increasing numbers of medical professionals are becoming aware of this need and are formulating ways to treat patients with their personal needs in mind. “In Depth” will explore more about how to go about caring for people with chronic health conditions in the upcoming episode.

“In Depth” with Laurence Fishburne is cautiously inspected before revealed to a public audience. The informational show has received numerous accolades for its endeavors.

Share article on social media or email: